Home / Compare
Side by side.
Facts on commonly compared compounds: what each one is, its regulatory status, what the trials show and the known risks. No recommendations.
vsSemaglutide vs TirzepatideHow the two most prescribed weight-management drugs differ: what they act on, what each is approved for, and what the one head-to-head trial found.vsTirzepatide vs RetatrutideTirzepatide is approved and widely prescribed. Retatrutide, often called Reta, is still experimental. Here is how they differ and why the trial numbers cannot be compared directly.vsSemaglutide vs LiraglutideTwo GLP-1 drugs from the same maker: liraglutide, the earlier daily injection, and semaglutide, the weekly one that largely replaced it. Here is what the head-to-head trial found.vsBPC-157 vs TB-500Two unapproved peptides that are often sold together for injury recovery. Here is what each one is, where they stand with FDA after the July 2026 advisory vote, and how thin the evidence is.vsSermorelin vs TesamorelinBoth prompt the pituitary gland to release growth hormone. One is an approved drug with a single narrow use; the other was approved, discontinued and is now compounded.